Vireo Health International (CSE: VREO) (OTCQX: VREOF) - Investor Dashboard


Vireo Health
CSE Ticker: VREO
OTCQX Ticker: VREOF
Market Focus: United States
Classification: Vertically Integrated
Country: United States
Employees: > 400 (October 2019)
Established: 2012
CEO: Kyle Kingsley, M.D.

Vireo – Management Team


Kyle Kingsley, M.D.
CEO

Dr. Kingsley is a board-certified emergency medicine physician and Chief Executive Officer of Vireo Health. Dr. Kingsley oversaw the implementation of the Vireo Health System in Minnesota with the construction of a state-of-the-art greenhouse facility, four dispensaries, and the pharmaceutical and patient care center models. Through Vireo Health of New York and other national startup companies, Dr. Kingsley has developed the leadership and healthcare management skills needed for a large-scale endeavors across disparate processes. Dr. Kingsley is co-author of the book Medical Cannabis Primer for Healthcare Providers, written to elucidate objective medical cannabis knowledge in the medical community. Using comprehensive, state-wide programs that integrate healthcare providers, Dr. Kingsley’s solitary goal is to make Vireo Health the safest, most reliable, and compassionate choice for the patients in all of the States in which the company operates.

Bruce Linton
Executive Chairman

Bruce Linton joined Vireo in November 2019. As Executive Chairman, Mr. Linton serves on the board of directors, works closely with Vireo CEO & Founder Kyle Kingsley, M.D., and spearheads the Company’s strategic decision-making, capital markets activity and partnerships. Mr. Linton is the founder and former CEO of Canopy Growth Corporation (“Canopy Growth”) and co-founder of Tweed Marijuana Incorporated. Under Mr. Linton’s leadership, Canopy Growth was the first cannabis producing company in North America to be listed on a major stock exchange (TSX) and included on a major stock index (S&P/TSX Composite Index). Canopy Growth was also the first cannabis-producing company to list on the New York Stock Exchange.

Shaun Nugent
Chief Financial Officer

Mr. Nugent will work closely with Chief Executive Officer (“CEO”) & Founder Kyle Kingsley, MD and Bruce Linton, Executive Chairman to optimize profitable growth, capital markets, and operating efficiencies. Mr. Nugent has previously served as the CEO and CFO of several major private and public companies, including Life Time Fitness, AllOver Media, Champps Entertainment, and Sun Country Airlines. He is an accomplished finance executive with over 25 years of executive management experience and has raised and deployed more than US$1 billion of capital throughout his career. Nugent’s financial leadership experience extends across multiple industries. In 2014, he was named ‘CFO of the Year’ by Twin Cities Business in recognition of his many accomplishments, which include doubling a media company’s revenue and enhancing EBITDA by 30%, scaling a national fitness firm’s revenues from less than $10M to over $200M with associated EBITDA in excess of $50M, and transforming a regional airline with one old aircraft into a profitable international commercial carrier with over $350M in annual revenue. Mr. Nugent is a Certified Public Account (Inactive) and a graduate of the University of Wisconsin with a B.A. in Accounting.

Amber Shimpa
Chief Administrative Officer

As CAO, Ms. Shimpa will continue to lead the Company’s human resources and business administration teams and further drive the integration of people and culture for Vireo. She will work closely with Chief Executive Officer (“CEO”) & Founder Kyle Kingsley to perpetuate Vireo’s core values and culture as its workforce continues to rapidly expand. Ms. Shimpa will also spearhead Vireo’s Corporate Social Responsibility initiatives and Diversity and Inclusion programs. Ms. Shimpa serves on Vireo’s Board of Directors and is a member of the Nominating and Governance Committee. Ms. Shimpa has served as the Chief Financial Officer (“CFO”) for Vireo since 2014 and has been responsible for building the accounting, finance and human resources teams of the Company since its startup phase. Amber has established herself as an accomplished finance executive and has raised and deployed more than US$100 million of capital with Vireo since 2014. Prior to Vireo, Ms. Shimpa had 14 years of experience as a financial services professional with various commercial and investment banking organizations.

Ari Hoffnung
Chief Operating Officer

Ari Hoffnung serves as the Chief Operating Officer of Vireo Health. Mr. Hoffnung was previously the founder and CEO of Fiorello Pharmaceuticals, Inc., a medical cannabis company. Prior to that, Mr. Hoffnung served as New York City’s Deputy Comptroller for Budget & Public Affairs, where he oversaw the City’s $70 billion budget, managed a 100+ employee staff, and served as the chief liaison to all levels of governments and to various labor unions. Prior to serving in New York City government, Mr. Hoffnung was a Managing Director at Bear Stearns, where he worked for more than a decade. Mr. Hoffnung also led a research team composed of economists and policy experts that published two-dozen white papers, including two ground-breaking and widely-cited reports on the public-health and economic impacts of reforming cannabis policies: 100,000 Reasons: Medical Marijuana In The Big Apple and Regulating and Taxing Marijuana: The Fiscal Impact on NYC. He holds an Masters of Business Administration in Finance degree from New York University’s Stern School of Business and a Bachelor’s degree from Queens College.

Stephen Dahmer, M.D.
Chief Medical Officer

Dr. Stephen M. Dahmer is the Chief Medical Officer at Vireo Health and a board-certified family doctor whose passion for health and healing has taken him around the globe. A fellow of the Arizona Center for Integrative Medicine, for over a decade he has studied the relationships between plants and people, working closely with diverse cultures and documenting their uses of plants. Aspiring to understand ethnomedical systems, as well as the plants and traditional beliefs that support them, Dr. Dahmer has worked in divergent settings including Umbanda terreiros in the heart of Brazil’s second largest slum, Maori clinics in New Zealand, native healers on the Palauan Islands, and as a hospitalist to the Navajo (Dine) Tribe in Chinle, Arizona. Prior to starting full time work for Vireo Health of New York, Dr. Dahmer was most recently Assistant Clinical Professor of Family Medicine and Community Health at the Icahn School of Medicine at Mount Sinai where he passionately provided innovative primary care for over seven years in New York City where he lives and resides with his family.

Eric Greenbaum, JD
Chief Science Officer

Eric Greenbaum is the Chief Science Officer of Vireo Health and has an impressive combination of scientific and legal expertise. Eric began his career working on stem cell and gene therapies for neurometabolic diseases. He went on to explore the role of protein folding in neurodegenerative diseases and led the team that performed the first biochemical characterization of the newly discovered E46K mutation responsible for a form of early onset Parkinson‘s Disease. After leaving academic science, Eric ran a boutique IP law firm where he crafted global patent strategies for biotech and pharmaceutical inventions. Since joining Vireo Health, Eric has been instrumental in developing our IP portfolio and driving our R&D efforts. Eric received a bachelors of science from Emory University in neuroscience; a masters of science from the University of Pennsylvania in pharmacology; and a JD from St. John’s University.

Harris Rabin
Chief Marketing Officer

Harris Rabin will be joining the company’s executive team in the newly created role of Chief Marketing Officer. Rabin will be overseeing brand marketing, e-commerce, and sales efforts. Rabin brings two decades of experience, including senior leadership roles in the consumer healthcare and beverage alcohol industries. Rabin is an accomplished marketing leader with a proven and consistent track record. He most recently served as Global Vice President of Marketing at Anheuser-Busch InBev (ABInBev), where he led brand building efforts for a multi-billion dollar global portfolio of core beer brands. Rabin led brand development across global markets, including the global expansion of Michelob Ultra, the $1+ billion brand pioneering the “Better-For-You” category. Prior to ABInBev, Rabin worked for nearly a decade at Bayer HealthCare as a brand builder in the Consumer Health division, where he built brands and ultimately oversaw the Global Aspirin franchise, growing the Aspirin business to the highest on record, consistently exceeding expectations. Rabin has a bachelor’s degree with high honors in mathematics & economics from Northwestern University, and an MBA from MIT Sloan School of Management with a focus on marketing and new product development. He lives in NYC with his wife and three children.

Michael Schroeder
General Counsel

Michael Schroeder serves as Vireo Health’s General Counsel and Chief Compliance Officer. Michael has been an attorney for over 25 years, including 6 years in law firm practice in the New York City area and the balance as an in-house attorney. He served as General Counsel for two public companies prior to Vireo Health and worked for companies in a variety of industries. He also oversaw the compliance function at two companies prior to Vireo Health. Michael has broad expertise in the law, including corporate structuring and transactions, securities, employment, contracts, real estate, capital markets, intellectual property, international trade, litigation management, dispute resolution, and administrative law. Michael received a Bachelor of Science, magna cum laude, in Business with a concentration in Finance from the University of Colorado at Boulder and a J.D. from Duke University. He joined Vireo Health for the opportunity to use his legal and compliance expertise to help a growing company navigate a complex industry with robust and ever-changing laws and regulations.

Significant Insider Ownership


Kyle Kingsley, CEO:
6.54 million shares (through Super Voting Shares)

Ari Hoffnung, COO:
23K shares and 2.4 million options

Amber Shimpa, CAO:
876K shares (through Subordinated Voting Shares and Multiple Voting Shares) and 2.91 million options

Stephen Dahmer, Chief Medical Officer:
1.95 million options

Eric Greenbaum, Chief Science Officer:
1.5 million options

Jacob Schroeder, General Counsel and Chief Compliance Officer:
1.05 million options

Gary Starr, Senior Vice President of Global Affairs & Chief Quality Officer:
600K options

Chad Martinson, Director:
180K shares (through Subordinated Voting Shares and Multiple Voting Shares)

Judd Norquist, Director:
108K shares (through Subordinated Voting Shares and Multiple Voting Shares)


Visit Vireo Health International, Inc.
at www.vireohealth.com.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Vireo Health International, Inc. is a client of NCV Media, LLC. Read our full disclaimer.